首页 | 期刊导航 | 学习空间 | 退出

期刊文章列表

  • Fangfang Wang1,2,Sora Jin3,Franklin Mayca Pozo3,Danmei Tian1,2,Xiyang Tang1,2,Yi Dai1,2,Xinsheng Yao1,2,Jinshan Tang1,2,Youwei Zhang3(Institute of Traditional Chinese Medicine and Natural Products,College of Pharmacy,Jinan University;Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drug Research,Jinan University;Department of Pharmacology,Case Comprehensive Cancer Center,Case Western Reserve University School of Medicine).Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Cutler T.Lewandowski1,Megan S.Laham2,Gregory R.J.Thatcher2(Department of Pharmaceutical Sciences,University of Illinois College of Pharmacy;Department of Pharmacology and Toxicology,University of Arizona College of Pharmacy).Remembering your A, B, C’s:Alzheimer’s disease and ABCA1[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Pearl Moharil,Zhuoya Wan,Apurva Pardeshi,Jiang Li,Haozhe Huang,Zhangyi Luo,Sanjay Rathod,Ziqian Zhang,Yuang Chen,Bei Zhang,Christian A.Fernandez,Jingjing Sun,Song Li(Center for Pharmacogenetics,Department of Pharmaceutical Science,School of Pharmacy,University of Pittsburgh).Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy:Dual targeting of tumor cells and tumor-associated macrophages[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Sha-Sha Cheng1,Yuan-Qing Qu2,Jia Wu1,Guan-Jun Yang1,3,4,Hao Liu5,Wanhe Wang5,6,Qi Huang2,Feng Chen1,Guodong Li1,Chun-Yuen Wong7,Vincent Kam Wai Wong2,Dik-Lung Ma5,Chung-Hang Leung1,8(Institute of Chinese Medical Sciences and State Key Laboratory of Quality Research in Chinese Medicine,University of Macau;Dr.Neher's Biophysics Laboratory for Innovative Drug Discovery,State Key Laboratory of Quality Research in Chinese Medicine,Macau University of Science and Technology;State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products,Ningbo University;Laboratory of Biochemistry and Molecular Biology,School of Marine Sciences,Ningbo University;Department of Chemistry,Hong Kong Baptist University;Institute of Medical Research,Northwestern Polytechnical University;Department of Chemistry,City University of Hong Kong;Department of Biomedical Sciences,Faculty of Health Sciences,University of Macau).Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Han Xiao1,2,Rui Zhang1,Xiaobo Fan1,Xinglu Jiang1,Mingyuan Zou1,Xuejiao Yan3,Haiping Hao4,Guoqiu Wu5,6(Medical School,Southeast University;Department of Clinical Laboratory,the Fifth Affiliated Hospital of Sun Yat-sen University;Department of Cardiology,the Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University;State Key Laboratory of Natural Medicines,Key Lab of Drug Metabolism and Pharmacokinetics,China Pharmaceutical University;Center of Clinical Laboratory Medicine,Zhongda Hospital,Southeast University;Jiangsu Provincial Key Laboratory of Critical Care Medicine,Southeast University).Super-sensitive bifunctional nanoprobe:Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Min-Xia Su1,Yu-Lian Xu1,Xiao-Ming Jiang1,Mu-Yang Huang1,Le-Le Zhang1,Luo-Wei Yuan1,Xiao-Huang Xu1,Qi Zhu1,Jian-Li Gao2,Jia-Hong Lu1,Xiuping Chen1,Ming-Qing Huang3,Yitao Wang1,Jin-Jian Lu1,4(State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau;School of Pharmaceutical Sciences,Zhejiang Chinese Medical University;College of Pharmacy,Fujian University of Traditional Chinese Medicine;Mo E Frontiers Science Center for Precision Oncology,University of Macau).c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Fengfeng Li1,2,Man Jiang1,2,Minghui Ma1,2,Xuyang Chen1,2,Yidan Zhang1,2,Yixin Zhang1,2,Yuanyuan Yu1,2,Yunfeng Cui1,2,Jiahui Chen1,2,Hui Zhao1,2,Zhijie Sun3,Deli Dong1,2,3(Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University;Translational Medicine Research and Cooperation Center of Northern China,Heilongjiang Academy of Medical Sciences,Harbin Medical University;Department of Pharmacology,China Pharmaceutical University).Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Wenhui Tao1,Dongyang Zhao1,Guanting Li1,Lingxiao Li1,Songhao Li1,Hao Ye1,Chutong Tian1,Yutong Lu1,Shuying Li2,Yinghua Sun3,Zhonggui He1,Jin Sun1(Department of Pharmaceutics,Wuya College of Innovation,Shenyang Pharmaceutical University;Department of Pharmaceutical and Engineering,College of Pharmaceutical and Engineering,Shenyang Pharmaceutical University;Department of Pharmaceutics,College of Pharmacy,Shenyang Pharmaceutical University).Artificial tumor microenvironment regulated by first hemorrhage for enhanced tumor targeting and then occlusion for synergistic bioactivation of hypoxia-sensitive platesomes[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Shuhua Shan1,Jinping Niu1,Ruopeng Yin1,Jiangying Shi1,Lizhen Zhang2,Caihong Wu1,Hanqing Li2,Zhuoyu Li1,2(Institute of Biotechnology,Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,Shanxi University;School of Life Science,Shanxi University).Peroxidase from foxtail millet bran exerts anticolorectal cancer activity via targeting cellsurface GRP78 to inactivate STAT3 pathway[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Fangyu Du1,Ruolin Cao1,Lu Chen1,Jianwen Sun1,Yajie Shi1,Yang Fu1,Bruce D.Hammock2,Zhonghui Zheng3,Zhongbo Liu4,Guoliang Chen1(Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education,School of Pharmaceutical Engineering,Shenyang Pharmaceutical University;Department of Entomology and Nematology and UC Davis Comprehensive Cancer Center,University of California Davis;Shandong Xinhua Pharmaceutical Co.,Ltd.;School of Pharmacy,Shenyang Pharmaceutical University).Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Ying Zhang1,Tao Wang1,Xiaojun Zhang2,Winnie Deuther-Conrad3,Hualong Fu1,Mengchao Cui1,Jinming Zhang2,Peter Brust3,4,Yiyun Huang5,Hongmei Jia1(Key Laboratory of Radiopharmaceuticals (Beijing Normal University),Ministry of Education,College of Chemistry,Beijing Normal University;Nuclear Medicine Department,Chinese PLA General Hospital;Helmholtz-Zentrum Dresden-Rossendorf,Institute of Radiopharmaceutical Cancer Research,Department of Neuroradiopharmaceuticals;The Lübeck Institute of Experimental Dermatology,University Medical Center Schleswig-Holstein;PET Center,Department of Radiology and Biomedical Imaging,Yale University School of Medicine).Discovery and development of brain-penetrant 18F-labeled radioligands for neuroimaging of the sigma-2 receptors[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Wei Xie1,Shuanghuan Liu2,Guanqiao Li3,Huiyan Xu1,Liyun Zhou1(Pharmcube (Beijing) Co.,Ltd.;National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College;Tsinghua Clinical Research Institute (TCRI),School of Medicine,Tsinghua University).The evolving treatment paradigm of lung cancer in China[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Peng Teng1,Jianfeng Cai2(College of Pharmaceutical Sciences,Zhejiang University;Department of Chemistry,University of South Florida).Using proteomimetics to switch angiogenic signaling[J].Acta Pharmaceutica Sinica B,2022,第3期
  • Danyu Du1,Chan Liu1,Mengyao Qin1,Xiao Zhang1,Tao Xi2,Shengtao Yuan3,Haiping Hao1,4,5,Jing Xiong1(Department of Pharmacology,School of Pharmacy,China Pharmaceutical University;Research Center of Biotechnology,School of Life Science and Technology,China Pharmaceutical University;Jiangsu Key Laboratory of Drug Screening,China Pharmaceutical University;State Key Laboratory of Natural Medicines,China Pharmaceutical University;Key Laboratory of Drug Metabolism and Pharmacokinetics,China Pharmaceutical University).Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Xiang Wang1,2,Xinxin Chen3,Wenqian Zhou1,2,Hongbo Men1,2,Terigen Bao1,2,Yike Sun1,2,Quanwei Wang2,Yi Tan1,4,Bradley B.Keller4,5,6,Qian Tong2,Yang Zheng2,Lu Cai1,4(Pediatric Research Institute,Department of Pediatrics,University of Louisville School of Medicine;Department of Cardiovascular Disease,the First Hospital of Jilin University;Department of Burn Surgery,First Hospital of Jilin University,Jilin University;Department of Pharmacology and Toxicology,University of Louisville School of Medicine;Pediatric Heart Research Program,Cardiovascular Innovation Institute,University of Louisville School of Medicine;Cincinnati Children's Heart Institute,Greater Louisville and Western Kentucky Practice).Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Makhloufi Zoulikha1,Qingqing Xiao1,George Frimpong Boafo1,Marwa A.Sallam2,Zhongjian Chen3,Wei He1,3(Department of Pharmaceutics,School of Pharmacy,China Pharmaceutical University;Department of Industrial Pharmacy,Faculty of Pharmacy,Alexandria University;Shanghai Skin Disease Hospital,Tongji University School of Medicine).Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Eugenia Trushina1,2,Sergey Trushin1,Md Fayad Hasan1(Department of Neurology,Mayo Clinic;Department of Molecular Pharmacology and Experimental Therapeutics,Mayo Clinic).Mitochondrial complex I as a therapeutic target for Alzheimer’s disease[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Guoyou Xie1,Xu-Nian Wu1,Yuyi Ling1,Yalan Rui1,Deyan Wu1,Jiawang Zhou1,Jiexin Li1,Shuibin Lin2,Qin Peng3,Zigang Li3,Hongsheng Wang1,3,Hai-Bin Luo1,4(School of Pharmaceutical Sciences,Sun Yat-sen University;Center for Translational Medicine,the First Affiliated Hospital,Sun Yat-sen University;Institute of Systems and Physical Biology,Shenzhen Bay Laboratory;Key Laboratory of Tropical Biological Resources of Ministry of Education,School of Life and Pharmaceutical Sciences,Hainan University).A novel inhibitor of N~6-methyladenosine demethylase FTO induces m RNA methylation and shows anti-cancer activities[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Xumin Zhou1,Libin Zou1,Hangyu Liao2,Junqi Luo1,Taowei Yang1,Jun Wu1,Wenbin Chen1,Kaihui Wu1,Shengren Cen1,Daojun Lv3,Fangpeng Shu4,Yu Yang5,Chun Li6,Bingkun Li1,Xiangming Mao1(Department of Urology,Zhujiang Hospital,Southern Medical University;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University;Department of Urology,Peking University Shenzhen Hospital;Nursing Department,Nanfang Hospital,Southern Medical University).Abrogation of Hn RNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Lifang Zhao,Hongyan Zhang,Xueqing Liu,Shan Xue,Dongfang Chen,Jing Zou,Handong Jiang(Department of Respiratory and Critical Care Medicine,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University).TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Shenghua Gao1,Tianguang Huang1,Letian Song1,Shujing Xu1,Yusen Cheng1,Srinivasulu Cherukupalli1,Dongwei Kang1,2,Tong Zhao1,Lin Sun1,Jian Zhang1,Peng Zhan1,2,Xinyong Liu1,2(Department of Medicinal Chemistry,Key Laboratory of Chemical Biology,Ministry of Education,School of Pharmaceutical Sciences,Cheeloo College of Medicine,Shandong University;China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province).Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Kongzhen Hu1,Junqi Li2,Lijuan Wang1,Yong Huang1,3,Li Li1,Shimin Ye1,Yanjiang Han1,Shun Huang1,Hubing Wu1,Jin Su2,4,Ganghua Tang1(Department of Nuclear Medicine,Nanfang Hospital,Southern Medical University;Shenzhen International Institute for Biomedical Research;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University).Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Qiubing Chen1,2,Qian Li2,Yuqi Liang1,Menghang Zu1,2,Nanxi Chen1,Brandon S.B.Canup3,Liyong Luo4,Chenhui Wang5,Liang Zeng4,Bo Xiao1,2(State Key Laboratory of Silkworm Genome Biology,College of Sericulture,Textile,and Biomass Sciences,Southwest University;Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing,School of Materials and Energy,Southwest University;Department of Chemistry,Center for Diagnostics and Therapeutics,Georgia State University;College of Food Science,Southwest University;Chongqing Key Laboratory of Natural Product Synthesis and Drug Research,School of Pharmaceutical Sciences,Chongqing University).Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Hang Qi1,Yuntao Shi2,Han Wu1,Canyang Niu1,Xiaoying Sun1,3,Ke Wei Wang1,3(Department of Pharmacology,School of Pharmacy,Qingdao University;State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University;Institue of Innovative Drugs,Qingdao University).Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Yan Zhang1,2,Pin Lv3,Junmei Ma2,Ning Chen3,Huishan Guo3,Yan Chen4,Xiaoruo Gan3,Rong Wang3,Xuqiang Liu4,Sufang Fan2,Bin Cong1,5,Wenyi Kang4(Hebei Key Laboratory of Forensic Medicine,College of Forensic Medicine,Hebei Medical University;Hebei Food Safety Key Laboratory,Hebei Food Inspection and Research Institute;Cardiovascular Medical Science Center,Department of Cell Biology,Hebei Medical University;National R & D Center for Edible Fungus Processing Technology,Henan University;Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology,Chinese Academy of Medical Sciences).Antrodia cinnamomea exerts an anti-hepatoma effect by targeting PI3K/AKT-mediated cell cycle progression in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Xin Sun1,Yuhan Shu2,Guiqin Ye3,Caixia Wu4,Mengting Xu2,Ruilan Gao5,Dongsheng Huang3,Jianbin Zhang4(Department of Oncology,Cancer Center of Zhejiang Provincial People's Hospital,Affiliated People's Hospital,Hangzhou Medical College;College of Biomedical Engineering & Instrument Science,Zhejiang University;Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province,Hangzhou Medical College;Clinical Research Institute,Zhejiang Provincial People's Hospital,Affiliated People's Hospital,Hangzhou Medical College;Department of Hematology,the First Affiliated Hospital of Zhejiang Chinese Medical University).Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylationmediated mitophagy[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Yan Yan1,2,Cancan Du1,Xixi Duan1,Xiaohan Yao1,Jiajia Wan1,Ziming Jiang3,Zhongyu Qin4,Wenqing Li1,Longze Pan1,Zhuoyu Gu1,Fazhan Wang1,Ming Wang1,Zhihai Qin1,2,5(Medical Research Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou University;Academy of Medical Sciences,Zhengzhou University;Department of Urology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou University;Changzhi Medical College;Institute of Biophysics,Chinese Academy of Sciences).Inhibiting collagen Ⅰ production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-/liposome-based nanovesicles[J].Acta Pharmaceutica Sinica B,2022,第2期
  • Hong Chen1,Lijun Sun1,Lu Feng1,Michael Mulholland2,Weizhen Zhang1,2,Yue Yin1(Department of Physiology and Pathophysiology,School of Basic Medical Sciences,Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Peking University;Department of Surgery,University of Michigan Medical Center).Peptidoglycan inhibits beigeing of adipose tissue[J].Acta Pharmaceutica Sinica B,2022,第2期
首页 上一页 7 8 9 10 11 下一页 尾页 共有11页,转到 页

帮助 | 繁體中文 | 关于发现 | 联系我们

超星发现系统 Copyright©·powered by 超星

客服电话:4008236966